Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 22.49
+0.11 (0.49%)
Feb 4, 2026, 3:00 PM CST
Thalys Medical Technology Group Company Description
Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China.
It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products.
The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer.
The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020.
Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.
Thalys Medical Technology Group Corporation
| Country | China |
| Founded | 2004 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,246 |
| CEO | Zheng Wang |
Contact Details
Address: No. 1310 Jinshan Avenue Wuhan, 430040 China | |
| Phone | 86 40 0680 2088 |
| Website | thalys.net.cn |
Stock Details
| Ticker Symbol | 603716 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000030C3 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Zheng Wang | GM and Director |
| Yan Shen | Chief Financial Officer |
| Xiao Ming Wen | Director of GM Office and Director |
| Li Fan | Deputy GM, Secretary of the Board and Director |
| Yi Lu | Deputy GM and Employee Director |
| Si Yan Huang | Accounting Supervisor |
| Jun Sun | Administrative Director |
| Feng Liu | GM of SPD Business and Regional Inspection Center Business Department and Deputy GM |